Breast cancer and hormone-replacement therapy in the Million Women Study (Q34223870)

31 July 2017

Breast cancer and hormone-replacement therapy in the Million Women Study. (English)

1 reference

Hormone Replacement Therapy

31 July 2017

1 reference

1 reference

1

Valerie Beral

1 reference

PubMed ID

12927427

Million Women Study Collaborators

31 July 2017

series ordinal

2

object named as

Million Women Study Collaborators

1 reference

PubMed ID

12927427

31 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

362

1 reference

31 July 2017

419-427

1 reference

31 July 2017

9382

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Comparison of various characteristics of women who do and do not attend for breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Estrogen-progestin replacement therapy and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914065-2

7 January 2021

10.1016/S0140-6736(03)14065-2

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12927427